LCI NYSE
Lannett Company, Inc.
1W: +47.4%
1M: -79.3%
3M: -98.7%
1Y: -99.6%
3Y: -100.0%
5Y: -100.0%
$0.69
Last traded 2023-05-23 — delisted
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Supply Chain Overview
2 relationships0
As Filer
counterparties named
2
As Counterparty
mentioned by others
2021-12-02
Earliest Filing
2021-12-02
Latest Filing
Mentioned As Counterparty
2 mentionsOther companies that named LCI in their SEC 8-K filings.
| Filed By | Relationship | Summary | Filing Date | SEC |
|---|---|---|---|---|
| ELTP ELITE PHARMACEUTICALS INC /NV/ | partner | Elite Pharmaceuticals renewed a License, Supply and Distribution Agreement with Lannett to market generic Dantrolene Cap | 2021-12-02 | View |
| ELTP ELITE PHARMACEUTICALS INC /NV/ | partner | Elite Pharmaceuticals renewed a license, supply, and distribution agreement with Lannett to market two generic Adderall | 2021-12-02 | View |
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text.
Covers 2021–2026. View on SEC EDGAR